| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101295104-B1 |
| titleOfInvention |
Promoters of Regeneration of Pancreatic β Cells and Promoters of Insulin Production of Pancreatic β Cells |
| abstract |
The present invention relates to a pharmaceutical agent that promotes the production or secretion of pancreatic β cells that produce and secrete insulin, including ghrelin or a derivative thereof, as an active ingredient, and a pharmaceutical agent that promotes insulin production in β cells. |
| priorityDate |
2005-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |